Clinical Trial

A Study of Retinal Imaging to Detect Abnormal Protein Deposits Associated With Alzheimer's Disease

Name: A Study of Retinal Imaging to Detect Abnormal Protein Deposits Associated With Alzheimer's Disease — clinical trial record (NCT07254234)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this study is to test the use of a screening tool to detect changes in the eye that are associated with Alzheimer's disease in adult participants with memory issues. For each participant, the study will last up to one month and requires one visit to the research site.

Trial Details

NCT Number	NCT07254234
Lead Sponsor	Eli Lilly and Company
Conditions	Cognitive Dysfunction, Memory Disorders
Enrollment	200 participants
Start Date	2025-12
Primary Completion	2026-08 (estimated)
Study Completion	2026-08 (estimated)
Updated on ClinicalTrials.gov	2025-11-28